RNA interference may be more potent than antisense RNA in human cancer cell lines
- 31 January 2003
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 30 (1-2) , 96-102
- https://doi.org/10.1046/j.1440-1681.2003.03801.x
Abstract
1. RNA interference (RNAi) is a newly discovered cellular pathway for the silencing of sequence‐specific genes at the mRNA level by the introduction of the cognate double‐stranded (ds) RNA . Because ...Keywords
This publication has 43 references indexed in Scilit:
- RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell linesCancer Gene Therapy, 2003
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- Ancient Pathways Programmed by Small RNAsScience, 2002
- Expanding small RNA interferenceNature Biotechnology, 2002
- Potential tumor-targeting peptide vector of histidylated oligolysine conjugated to a tumor-homing RGD motifCancer Gene Therapy, 2001
- Antisense therapy in oncology: new hope for an old idea?The Lancet, 2001
- RNA Interference for the Organizer-Specific Gene Xlim-1 in Xenopus EmbryosBiochemical and Biophysical Research Communications, 2000
- Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?Antisense and Nucleic Acid Drug Development, 2000
- RNAiCell, 2000
- Heritable and inducible genetic interference by double-stranded RNA encoded by transgenesNature Genetics, 2000